Skip to content

Insider · CIK 0001963664

Yingli Ma

officer

Files at GPCR (Structure Therapeutics Inc.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 19, 2026GPCR
Structure Therapeutics Inc.
AGrant or award
Ordinary Shares
+32,526$0.00$0139,917Mar 23, 2026
Mar 19, 2026GPCR
Structure Therapeutics Inc.
AGrant or award
Employee Stock Option (right to buy)derivative
+40,278$0.00$040,278Mar 23, 2026
Mar 3, 2026GPCR
Structure Therapeutics Inc.
FTax withholding
Ordinary Shares
-11,313$20.99$237k107,391Mar 5, 2026
Jul 1, 2025GPCR
Structure Therapeutics Inc.
FTax withholding
Ordinary Shares
-4,470$6.84$31k118,704Aug 20, 2025
Mar 1, 2025GPCR
Structure Therapeutics Inc.
FTax withholding
Ordinary Shares
-1,824$7.92$14k98,715Jul 3, 2025
Jul 1, 2025GPCR
Structure Therapeutics Inc.
AGrant or award
Ordinary Shares
+24,459$0.00$0123,174Jul 3, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Yingli Ma: insider trades and track record | InsiderTell